Table 1 Comparison between SARS-CoV-2 and Dengue virus [1, 56, 57]
From: Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India
Features | Dengue | COVID-19 |
|---|---|---|
Cause | DENV | SARS-CoV-2 |
Emergence date | 1780 | December 2019 |
Place of emergence | Philadelphia | Wuhan, China |
Entry receptor | Heparan sulphate/DC-SIGN | ACE2 |
Genome type | Positive SS-RNA | Positive SS-RNA |
Protein composition | Three structural and seven non-structural protein | 16 proteins from ORF1a and 1b, and three structural protein, N protein and the other accessary proteins from subgenomic mRNA |
Genomic size | 11 kb | 27–32 kb |
Symptoms | High fever, rashes on-skin, nausea, vomiting, joint pain | Fever, cough, breathing difficulties, sneezing, vomiting |
Diagnostic method | RT-PCR, ELISA, NS1 antigen test | RT-PCR, ELISA, CT-Scan |
Total infected countries | 129 | 227 |
#Total cases | 390 million/year | 149 million/year |
#Total deaths | Estimated 40,000/year | 2,009,163/year |
Endemic/Pandemic | Endemic | Pandemic |
Cured/Or Not Cured | Not yet | Not yet |